Public tender offers under the German Securities Acquisition and Takeover Act: Offers, results and analyses -
Following the lapse of the takeover offer to the shareholders of QIAGEN B.V. caused by the failure to meet the reduced minimum acceptance condition at the end of the extended acceptance period and the completion of the mandatory offer to the shareholders of Vita 34 AG, there are presently no ongoing offer proceedings to report.
Please see full publication below for more information.